Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis.
about
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsDenosumab for the treatment of osteoporosisSafety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysisLong-term treatment of osteoporosis: safety and efficacy appraisal of denosumabBone Metastases: An Overview.Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complicationsDenosumab for the treatment of bone metastases in breast cancer: evidence and opinionTargeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility.Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targetsEvaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid.Denosumab: A comprehensive review.Low bone mineral density is not related to failure in femoral neck fracture patients treated with internal fixation.Denosumab--an emerging treatment for postmenopausal osteoporosis.The role and efficacy of denosumab in the treatment of osteoporosis: an update.Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict?Adverse drug reactions to osteoporosis treatments.Safety concerns with the long-term management of osteoporosis.Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients.The efficacy and safety of vertebral fracture prevention therapies in post-menopausal osteoporosis treatment: Which therapies work best? a network meta-analysis.
P2860
Q26824762-5940E7F5-7252-42F2-9827-4ABC3615D12EQ27009275-0E9D2C68-6BF8-4042-AB04-65C312F14028Q28242783-652FB03E-477B-4817-A358-4551B1149129Q28727655-C87B09AD-B31B-459B-BD9D-C5E784C76F69Q33727278-FFFA43DB-BE77-4C7D-A59D-BFBBE55E5878Q34090842-A62A02BE-6A97-4268-A9DD-D8317167316EQ34189582-D7E2F0CA-5D64-4F94-923D-807F723DC8FBQ34189897-DAC42D8A-45CE-4B56-ACCC-F077A53EA6DEQ34590994-968DB2EA-E5BC-4F5F-B753-4FD8ADF8C7B6Q35205280-F4C9B1D3-6DE6-46B9-A909-CE87612E7ACFQ36058895-CBE6B92C-FE7E-4771-BD02-3F215224164BQ36158922-5F56693E-17A6-448B-AF04-5F50DBF6BCFFQ36524247-5E21C719-2799-4EC2-9A9E-AC99CCDE81E1Q37467278-AE6CE758-2C08-4251-8095-51CD756FACE8Q37614724-01220471-4CF7-46B7-B2D8-C1F2095A5063Q37679921-4312B4B4-8590-4E9F-9015-EEA33164C7CFQ37826197-3B592DC1-9224-4F32-8BD7-AB7823440F55Q37829690-ED3B456D-15B9-4313-A5E1-0F651CBF48F9Q37944154-7C43BEEE-A7CD-4606-BED4-C6774B38C9C2Q37960410-051A40BA-E207-4ACD-855C-7445A028FB84Q37973355-C3E956AB-E103-4E42-99FD-CB9668A003D6Q38101363-0BF7AE8F-51AC-4F3D-A11B-F609FD2CA783Q40446999-178E0722-986D-40F9-8359-366097593BEAQ41204558-0C6C513E-2E39-4204-98E2-33EC03466069
P2860
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of denosum ...... ic review and a meta-analysis.
@en
Efficacy and safety of denosum ...... ic review and a meta-analysis.
@nl
type
label
Efficacy and safety of denosum ...... ic review and a meta-analysis.
@en
Efficacy and safety of denosum ...... ic review and a meta-analysis.
@nl
prefLabel
Efficacy and safety of denosum ...... ic review and a meta-analysis.
@en
Efficacy and safety of denosum ...... ic review and a meta-analysis.
@nl
P2093
P356
P1476
Efficacy and safety of denosum ...... tic review and a meta-analysis
@en
P2093
A D Anastasilakis
K A Toulis
S Delaroudis
P304
P356
10.1055/S-0029-1224109
P577
2009-06-17T00:00:00Z